...
iart-img

Integra LifeSciences Holdings, Common Stock

IART

NSQ

$23.71

-$0.32

(-1.33%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.85B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
533.99K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.08
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$16.8 L
$45.42 H
$23.71

About Integra LifeSciences Holdings, Common Stock

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameIARTSectorS&P500
1-Week Return-2.75%-3.72%-0.05%
1-Month Return5.42%-1.85%2.75%
3-Month Return36.89%-11.4%7.4%
6-Month Return-17.96%-4.41%10.47%
1-Year Return-44.6%4.13%27.57%
3-Year Return-62.57%0.3%29.56%
5-Year Return-60.15%36.62%89.3%
10-Year Return4.28%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue1.52B1.37B1.54B1.56B1.54B[{"date":"2019-12-31","value":97.43,"profit":true},{"date":"2020-12-31","value":88.07,"profit":true},{"date":"2021-12-31","value":99.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.97,"profit":true}]
Cost of Revenue564.68M520.83M597.81M587.36M653.18M[{"date":"2019-12-31","value":86.45,"profit":true},{"date":"2020-12-31","value":79.74,"profit":true},{"date":"2021-12-31","value":91.52,"profit":true},{"date":"2022-12-31","value":89.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit952.88M851.03M944.64M970.31M888.39M[{"date":"2019-12-31","value":98.2,"profit":true},{"date":"2020-12-31","value":87.71,"profit":true},{"date":"2021-12-31","value":97.35,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.56,"profit":true}]
Gross Margin62.79%62.03%61.24%62.29%57.63%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.8,"profit":true},{"date":"2021-12-31","value":97.54,"profit":true},{"date":"2022-12-31","value":99.21,"profit":true},{"date":"2023-12-31","value":91.78,"profit":true}]
Operating Expenses794.20M699.66M747.41M731.39M836.39M[{"date":"2019-12-31","value":94.96,"profit":true},{"date":"2020-12-31","value":83.65,"profit":true},{"date":"2021-12-31","value":89.36,"profit":true},{"date":"2022-12-31","value":87.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income178.98M151.37M197.23M238.92M111.53M[{"date":"2019-12-31","value":74.91,"profit":true},{"date":"2020-12-31","value":63.36,"profit":true},{"date":"2021-12-31","value":82.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.68,"profit":true}]
Total Non-Operating Income/Expense(162.05M)(120.13M)(26.21M)(62.70M)(64.63M)[{"date":"2019-12-31","value":-16205100000,"profit":false},{"date":"2020-12-31","value":-12013400000,"profit":false},{"date":"2021-12-31","value":-2621100000,"profit":false},{"date":"2022-12-31","value":-6270300000,"profit":false},{"date":"2023-12-31","value":-6463200000,"profit":false}]
Pre-Tax Income60.10M93.52M214.68M213.89M81.07M[{"date":"2019-12-31","value":28,"profit":true},{"date":"2020-12-31","value":43.56,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.64,"profit":true},{"date":"2023-12-31","value":37.76,"profit":true}]
Income Taxes9.90M(40.37M)45.60M33.34M13.33M[{"date":"2019-12-31","value":21.72,"profit":true},{"date":"2020-12-31","value":-88.53,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.12,"profit":true},{"date":"2023-12-31","value":29.23,"profit":true}]
Income After Taxes50.20M133.89M169.07M180.55M67.74M[{"date":"2019-12-31","value":27.8,"profit":true},{"date":"2020-12-31","value":74.16,"profit":true},{"date":"2021-12-31","value":93.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.52,"profit":true}]
Income From Continuous Operations50.20M133.89M169.07M180.55M67.74M[{"date":"2019-12-31","value":27.8,"profit":true},{"date":"2020-12-31","value":74.16,"profit":true},{"date":"2021-12-31","value":93.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.52,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income50.20M133.89M169.07M180.55M67.74M[{"date":"2019-12-31","value":27.8,"profit":true},{"date":"2020-12-31","value":74.16,"profit":true},{"date":"2021-12-31","value":93.64,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.52,"profit":true}]
EPS (Diluted)2.742.453.183.353.10[{"date":"2019-12-31","value":81.79,"profit":true},{"date":"2020-12-31","value":73.13,"profit":true},{"date":"2021-12-31","value":94.93,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.54,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IART
Cash Ratio 0.30
Current Ratio 1.20
Quick Ratio 0.73

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IART
ROA (LTM) 3.02%
ROE (LTM) -0.42%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IART
Debt Ratio Lower is generally better. Negative is bad. 0.63
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.37

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IART
Trailing PE NM
Forward PE 9.52
P/S (TTM) 1.17
P/B 1.20
Price/FCF NM
EV/R 2.26
EV/Ebitda 18.86
PEG 0.79

FAQs

What is Integra LifeSciences Holdings share price today?

Integra LifeSciences Holdings (IART) share price today is $23.71

Can Indians buy Integra LifeSciences Holdings shares?

Yes, Indians can buy shares of Integra LifeSciences Holdings (IART) on Vested. To buy Integra LifeSciences Holdings from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IART stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Integra LifeSciences Holdings be purchased?

Yes, you can purchase fractional shares of Integra LifeSciences Holdings (IART) via the Vested app. You can start investing in Integra LifeSciences Holdings (IART) with a minimum investment of $1.

How to invest in Integra LifeSciences Holdings shares from India?

You can invest in shares of Integra LifeSciences Holdings (IART) via Vested in three simple steps:

  • Click on Sign Up or Invest in IART stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Integra LifeSciences Holdings shares
What is Integra LifeSciences Holdings 52-week high and low stock price?

The 52-week high price of Integra LifeSciences Holdings (IART) is $45.42. The 52-week low price of Integra LifeSciences Holdings (IART) is $16.8.

What is Integra LifeSciences Holdings price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Integra LifeSciences Holdings (IART) is

What is Integra LifeSciences Holdings price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Integra LifeSciences Holdings (IART) is 1.20

What is Integra LifeSciences Holdings dividend yield?

The dividend yield of Integra LifeSciences Holdings (IART) is 0.00%

What is the Market Cap of Integra LifeSciences Holdings?

The market capitalization of Integra LifeSciences Holdings (IART) is $1.85B

What is Integra LifeSciences Holdings’s stock symbol?

The stock symbol (or ticker) of Integra LifeSciences Holdings is IART

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top